Description:
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2
BREAST CANCER 2, EARLY-ONSET; BRCA2
BREAST CANCER INFORMATION CORE (BIC) BRCA1/BRCA2 MUTATION PANEL DNA SAMPLES
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Hereditary Cancers |
Class |
Heritable Cancer Syndromes and other Cancers |
Quantity |
25 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
DNA from LCL
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization after cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
BRCA2 |
Chromosomal Location |
13q13.1 |
Allelic Variant 1 |
600185.0002; BREAST CANCER 2, EARLY-ONSET |
Identified Mutation |
2-BP DEL, 6503TT; By sequencing the putative BRCA2 gene in individuals with early-onset breast cancer who shared only the haplotype of 13q microsatellite markers that segregated with the disease, Wooster et al. (Nature 378: 789-792, 1995) a TT deletion in family CRC B211, respectively. |
Remarks |
Infiltrating adenocarcinoma of right breast and infiltrating ductal carcinoma of left breast; family history: father and uncle with prostate cancer, aunt with breast cancer, aunt with ovarian cancer, and uncle with lung cancer; frameshift mutation in BRCA2 gene is 6503delTT in exon 11, leading to a truncation at codon 2099 (R2092fsX2099) |
Atkins A, Gupta P, Zhang BM, Tsai WS, Lucas J, Javey M, Vora A, Mei R, Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection Molecular diagnosis & therapy: 2019 |
PubMed ID: 31209714 |
|
|